A cell therapy tools and therapeutics developer approached DeciBio to help inform its financial projections, valuation, and messaging to aid its IPO
Primary Research
Secondary Research
Quantitative Analysis
The client leveraged DeciBio's output on its IPO roadshow, ultimately leading to a successful, oversubscribed IPO.
13 weeks
U.S., Europe, APAC
Pharma & Biotech
Revenue Projection
Addressable Market Sizing
Novel Technology Commercialization